{"entity":{"id":"nct05744219","kind":"trial","name":"Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial","aka":["IRIS"],"tldr":"A phase 3 trial in pancreatic cancer, run by Jon Unosson, now recruiting.","summary":"Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial is a phase 3, randomised interventional study registered as NCT05744219 by Jon Unosson, with a registry enrolment figure of 338 participants, started 2024-09-04 and due to reach its primary completion in 2027-12-31. Interventions recorded: Ferric carboxymaltose; Placebo. Conditions listed: Surgery; Liver Metastases; Liver Cancer; Pancreas Cancer; Aortic Aneurysm. Primary outcome: Recovery after iv Iron. Pancreatic eligibility wording from the registry: \"Scheduled for complex aortic surgery, liver resection or pancreatic resection\". Sites: Sweden. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT05744219","url":"https://clinicaltrials.gov/study/NCT05744219"}],"tags":["ctgov-ingest","pancreatic-deep-dive"],"related":[],"cancers":["metastatic-pdac"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT05744219","phase":"3","setting":"Improved Recovery by Iron Following Surgery With Blood Loss, a Double-blind Multi-centre Randomized Controlled Phase III Drug Trial (the IRIS-trial)","sponsor":"Jon Unosson","enrolled":338,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct05744219/","neighbours":{"cancer":[{"id":"metastatic-pdac","kind":"cancer","name":"Metastatic pancreatic ductal adenocarcinoma","route":"/cancers/metastatic-pdac/"}],"term":[{"id":"pancreatic-trials-open-today","kind":"term","name":"Pancreatic cancer trials open today (registry snapshot and UK sites)","route":"/terms/pancreatic-trials-open-today/"}]}}